Royce & Associates LP Emergent Bio Solutions Inc. Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$27.42 - $43.63 $4.9 Million - $7.8 Million	-178,676 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$36.48 - $52.22 $77,337 - $110,706	2,120 Added 1.2%	178,676 $7.34 Million
Q4 2021 Feb 07, 2022	SELL	$33.11 - $55.01 $1.96 Million - $3.26 Million	-59,275 Reduced 25.13%	176,556 $7.68 Million
Q3 2021 Nov 10, 2021	BUY	$50.07 - $66.05 $47,115 - $62,153	941 Added 0.4%	235,831 $11.8 Million
Q2 2021 Aug 06, 2021	SELL	$56.61 - $80.46 $128,561 - $182,724	-2,271 Reduced 0.96%	234,890 $14.8 Million
Q1 2021 May 10, 2021	BUY	$86.23 - $125.19 $4.62 Million - $6.71 Million	53,579 Added 29.19%	237,161 $22 Million
Q4 2020 Feb 08, 2021	BUY	$79.17 - $111.47 $5.38 Million - $7.58 Million	68,017 Added 58.86%	183,582 $16.4 Million
Q3 2020 Nov 12, 2020	SELL	$81.91 - $134.94 $5.2 Million - $8.56 Million	-63,429 Reduced 35.44%	115,565 $11.9 Million
Q2 2020 Aug 07, 2020	SELL	$54.33 - $89.52 $1.2 Million - $1.97 Million	-22,000 Reduced 10.95%	178,994 $14.2 Million
Q1 2020 May 12, 2020	SELL	$49.34 - $68.76 $5.72 Million - $7.97 Million	-115,933 Reduced 36.58%	200,994 $11.6 Million
Q4 2019 Feb 06, 2020	BUY	$51.21 - $59.06 $892,026 - $1.03 Million	17,419 Added 5.82%	316,927 $17.1 Million
Q3 2019 Nov 13, 2019	BUY	$40.6 - $57.2 $2.38 Million - $3.35 Million	58,644 Added 24.35%	299,508 $15.7 Million
Q2 2019 Aug 12, 2019	BUY	$39.92 - $53.86 $9.39 Million - $12.7 Million	235,230 Added 4175.19%	240,864 $11.6 Million
Q1 2019 May 09, 2019	BUY	$48.23 - $66.16 $271,727 - $372,745	5,634 New	5,634 $285,000
Q4 2018 Feb 11, 2019	SELL	$55.63 - $73.24 $31,097 - $40,941	-559 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$52.05 - $66.51 $10,149 - $12,969	195 Added 53.57%	559 $37,000
Q2 2018 Aug 09, 2018	BUY	$48.33 - $55.64 $7,346 - $8,457	152 Added 71.7%	364 $18,000
Q1 2018 May 14, 2018	SELL	$44.44 - $54.39 $888 - $1,087	-20 Reduced 8.62%	212 $11,000
Q4 2017 Feb 09, 2018	SELL	$37.77 - $47.75 $982 - $1,241	-26 Reduced 10.08%	232 $11,000
Q3 2017 Nov 13, 2017	BUY	$34.14 - $40.45 $8,808 - $10,436	258	258 $10,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$31.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$27.5 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$20.2 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$18 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$15.5 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $404M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account